Chronic Stress (Thousand Oaks). 2019 Jan-Dec;3. doi: 10.1177/2470547019865267. Epub 2019 Aug 30.
Neurophysiological Correlates and Differential Drug Response in Subjects With a Family History of an Alcohol Use Disorder.
Chronic stress (Thousand Oaks, Calif.)
Sage M Comstock, Jatin G Vaidya, Mark J Niciu
Affiliations
Affiliations
- Department of Psychiatry, Iowa Neuroscience Institute, University of Iowa Health Care, Iowa City, IA, USA.
PMID: 31511840
PMCID: PMC6738944 DOI: 10.1177/2470547019865267
Abstract
A family history of an alcohol use disorder (AUD) has been shown to increase one's risk of developing an AUD. Additionally, a positive family history of AUD (family history positive (FHP)) has neurobiological and neuropsychopharmacological consequences, and this review summarizes differential drug response as well as neuroanatomical and neurocognitive correlates. FHP status is related to altered responses to a number of drugs, including substances with abuse liability like alcohol, opioids, amphetamines, and ketamine. FHP individuals demonstrate fewer aversive effects and more rewarding response to both alcohol and subanesthetic dose ketamine. Ketamine is a rapid-acting antidepressant, and several studies have reported that ketamine is more effective for FHP treatment-resistant depressed individuals. In short, the reviewed neurophysiological differences may contribute to ketamine's enhanced antidepressant efficacy in FHP patients. Volumetric differences in the amygdala, nucleus accumbens, neocortex, and cerebellum are commonly reported. Furthermore, FHP has also been associated with altered neurocognitive performance, e.g., increased impulsivity. The imaging and psychological literature supports a neurodevelopmental lag hypothesis in FHP youth. The review will further discuss these findings in depth.
Keywords: familial alcoholism; family history of alcohol dependence; ketamine; neuroimaging; treatment-resistant depression
Conflict of interest statement
Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
- Psychopharmacology (Berl). 2014 Jun;231(12):2385-93 - PubMed
- Psychol Med. 2004 Nov;34(8):1519-30 - PubMed
- PLoS One. 2014 Feb 04;9(2):e88188 - PubMed
- J Stud Alcohol. 1985 Jul;46(4):289-97 - PubMed
- Alcohol Clin Exp Res. 2002 Jun;26(6):827-35 - PubMed
- Alcohol Clin Exp Res. 2011 Aug;35(8):1426-34 - PubMed
- Alcohol Clin Exp Res. 2013 Mar;37(3):390-8 - PubMed
- Pharmacol Biochem Behav. 2011 Oct;99(4):696-703 - PubMed
- Addiction. 2008 Aug;103(8):1308-19 - PubMed
- Neuroimage Clin. 2017 Dec 12;17:1036-1046 - PubMed
- Hum Brain Mapp. 2014 Dec;35(12):5877-87 - PubMed
- Front Integr Neurosci. 2013 Mar 11;7:9 - PubMed
- Arch Gen Psychiatry. 1998 Nov;55(11):973-9 - PubMed
- Neuropsychopharmacology. 2013 Sep;38(10):1854-63 - PubMed
- J Stud Alcohol Drugs. 2015 Jan;76(1):47-56 - PubMed
- Biol Psychiatry. 2007 Sep 15;62(6):694-7 - PubMed
- J Stud Alcohol. 1993 Mar;54(2):219-24 - PubMed
- Bipolar Disord. 2012 Dec;14(8):880-7 - PubMed
- Drug Alcohol Depend. 2018 Apr 1;185:198-206 - PubMed
- Drug Alcohol Depend. 2010 Apr 1;108(1-2):1-6 - PubMed
- Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14259-64 - PubMed
- Alcohol Clin Exp Res. 2012 Apr;36(4):604-15 - PubMed
- Drug Alcohol Depend. 2012 Jun 1;123(1-3):98-104 - PubMed
- World J Biol Psychiatry. 2012 Jan;13(1):75-81 - PubMed
- Biol Psychiatry. 2007 Jun 1;61(11):1306-9 - PubMed
- J Stud Alcohol. 2000 Nov;61(6):827-35 - PubMed
- Psychiatry Res. 2011 Dec 30;194(3):304-313 - PubMed
- Addict Biol. 2017 Jan;22(1):218-228 - PubMed
- Neuropsychol Rev. 2010 Mar;20(1):1-20 - PubMed
- J Affect Disord. 2017 Jan 15;208:560-566 - PubMed
- Alcohol Clin Exp Res. 2002 Apr;26(4):441-8 - PubMed
- Alcohol Clin Exp Res. 2014 Dec;38(12):2944-51 - PubMed
- J Stud Alcohol. 2003 Mar;64(2):195-9 - PubMed
- Arch Gen Psychiatry. 1981 Aug;38(8):861-8 - PubMed
- Arch Gen Psychiatry. 2003 Jul;60(7):727-35 - PubMed
- Alcohol Clin Exp Res. 2012 Dec;36(12):2017-27 - PubMed
- Am J Psychiatry. 2004 Oct;161(10):1776-82 - PubMed
- Biol Psychiatry. 2011 Apr 1;69(7):675-83 - PubMed
- Psychiatry Res. 2005 Feb 28;138(2):115-30 - PubMed
- Clin Pharmacokinet. 2016 Sep;55(9):1059-77 - PubMed
- Drug Alcohol Depend. 2014 Nov 1;144:170-7 - PubMed
- J Clin Psychiatry. 2014 May;75(5):e417-23 - PubMed
- Am J Psychiatry. 1994 Feb;151(2):184-9 - PubMed
- J Psychiatr Res. 2011 Jul;45(7):980-8 - PubMed
- J Stud Alcohol Drugs. 2013 Mar;74(2):245-57 - PubMed
- Alcohol Clin Exp Res. 2002 Aug;26(8):1299-306 - PubMed
- Pharmacol Rev. 2018 Jul;70(3):621-660 - PubMed
- Addict Biol. 2007 Mar;12(1):122-32 - PubMed
- Alcohol Clin Exp Res. 2006 May;30(5):763-73 - PubMed
- Alcohol Clin Exp Res. 2003 Nov;27(11):1743-9 - PubMed
- Drug Alcohol Depend. 2011 Sep 1;117(2-3):198-203 - PubMed
- Psychol Med. 2017 Oct;47(13):2288-2301 - PubMed
- Drug Alcohol Depend. 2009 Feb 1;100(1-2):17-23 - PubMed
- Cerebellum. 2016 Dec;15(6):744-754 - PubMed
- Neurosci Lett. 2018 Apr 3;671:1-6 - PubMed
- Psychol Med. 2015 Apr;45(5):1061-72 - PubMed
- Alcohol Clin Exp Res. 1994 Aug;18(4):861-6 - PubMed
- Int J Neuropsychopharmacol. 2014 Oct 31;18(1): - PubMed
- Alcohol Clin Exp Res. 2013 Jan;37 Suppl 1:E161-71 - PubMed
- Neuroimage. 2011 Feb 14;54(4):2582-9 - PubMed
- Exp Clin Psychopharmacol. 2001 Feb;9(1):101-9 - PubMed
- Drug Alcohol Depend. 2015 May 1;150:38-45 - PubMed
- Biol Psychiatry. 2009 Jan 15;65(2):181-4 - PubMed
- JAMA Psychiatry. 2017 Sep 1;74(9):911-923 - PubMed
- Alcohol Clin Exp Res. 2006 Aug;30(8):1308-14 - PubMed
- Neuroimage. 2010 Mar;50(1):267-76 - PubMed
- Addiction. 2012 Oct;107(10):1774-85 - PubMed
- J Neuroophthalmol. 2005 Sep;25(3):217-26 - PubMed
- Psychol Addict Behav. 2001 Sep;15(3):204-9 - PubMed
- Science. 1984 Sep 28;225(4669):1493-6 - PubMed
- Biol Psychiatry. 2007 Jan 1;61(1):41-7 - PubMed
- Dev Psychopathol. 2005 Summer;17(3):785-806 - PubMed
- Alcohol Clin Exp Res. 2014 Jun;38(6):1639-45 - PubMed
- Addict Behav. 2003 Aug;28(6):1129-39 - PubMed
- Biol Psychiatry. 2001 Jun 1;49(11):894-905 - PubMed
- Psychol Med. 2014 Oct;44(13):2775-86 - PubMed
- Psychiatr Pol. 2014 Jan-Feb;48(1):35-47 - PubMed
- Alcohol Clin Exp Res. 2013 Jan;37 Suppl 1:E356-63 - PubMed
- World J Biol Psychiatry. 2013 Dec;14(8):565-73 - PubMed
- Biol Psychiatry. 2016 May 1;79(9):e69-e70 - PubMed
- Am J Drug Alcohol Abuse. 2010 May;36(3):161-7 - PubMed
- Dev Cogn Neurosci. 2015 Dec;16:147-154 - PubMed
- Am J Drug Alcohol Abuse. 2017 Jan;43(1):24-43 - PubMed
- Alcohol Clin Exp Res. 2018 Jan;42(1):89-99 - PubMed
- Neuropsychopharmacology. 2019 May;44(6):1076-1083 - PubMed
- Neuropsychopharmacology. 2015 Jan;40(2):412-20 - PubMed
- J Alcohol Drug Depend. 2013 Dec 12;Suppl 1: - PubMed
- Alcohol Clin Exp Res. 1985 Dec;9(6):498-502 - PubMed
Publication Types
Grant support